Laura Bertoccini, Marco Giorgio Baroni. Adv Exp Med Biol 2021
Times Cited: 4
Times Cited: 4
Times Cited
Times Co-cited
Similarity
Extraglycemic Effects of SGLT2 Inhibitors: A Review of the Evidence.
Benedetta Maria Bonora, Angelo Avogaro, Gian Paolo Fadini. Diabetes Metab Syndr Obes 2020
Benedetta Maria Bonora, Angelo Avogaro, Gian Paolo Fadini. Diabetes Metab Syndr Obes 2020
75
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
75
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
75
GLP-1 Receptor Agonists and Cardiovascular Disease in Patients with Type 2 Diabetes.
María Isabel Del Olmo-Garcia, Juan Francisco Merino-Torres. J Diabetes Res 2018
María Isabel Del Olmo-Garcia, Juan Francisco Merino-Torres. J Diabetes Res 2018
50
Treatment paradigm shifting implications of recent cardiovascular outcome trials: Core insights on the brink of the 2020ies.
Eberhard Standl, Oliver Schnell. Diabetes Res Clin Pract 2020
Eberhard Standl, Oliver Schnell. Diabetes Res Clin Pract 2020
50
GLP-1RAs in type 2 diabetes: mechanisms that underlie cardiovascular effects and overview of cardiovascular outcome data.
Andrei C Sposito, Otávio Berwanger, Luiz Sérgio F de Carvalho, José Francisco Kerr Saraiva. Cardiovasc Diabetol 2018
Andrei C Sposito, Otávio Berwanger, Luiz Sérgio F de Carvalho, José Francisco Kerr Saraiva. Cardiovasc Diabetol 2018
50
Antihypertensive effect of glucagon-like peptide 1 in Dahl salt-sensitive rats.
Ming Yu, Carol Moreno, Kimberly M Hoagland, Annette Dahly, Katie Ditter, Mahesh Mistry, Richard J Roman. J Hypertens 2003
Ming Yu, Carol Moreno, Kimberly M Hoagland, Annette Dahly, Katie Ditter, Mahesh Mistry, Richard J Roman. J Hypertens 2003
50
Effect of glucagon-like peptide-1 receptor agonists on lipid profiles among type 2 diabetes: a systematic review and network meta-analysis.
Feng Sun, Shanshan Wu, Jing Wang, Shuxia Guo, Sanbao Chai, Zhirong Yang, Lishi Li, Yuan Zhang, Linong Ji, Siyan Zhan. Clin Ther 2015
Feng Sun, Shanshan Wu, Jing Wang, Shuxia Guo, Sanbao Chai, Zhirong Yang, Lishi Li, Yuan Zhang, Linong Ji, Siyan Zhan. Clin Ther 2015
50
Impact of GLP-1 receptor agonists on blood pressure, heart rate and hypertension among patients with type 2 diabetes: A systematic review and network meta-analysis.
Feng Sun, Shanshan Wu, Shuxia Guo, Kai Yu, Zhirong Yang, Lishi Li, Yuan Zhang, Xiaochi Quan, Linong Ji, Siyan Zhan. Diabetes Res Clin Pract 2015
Feng Sun, Shanshan Wu, Shuxia Guo, Kai Yu, Zhirong Yang, Lishi Li, Yuan Zhang, Xiaochi Quan, Linong Ji, Siyan Zhan. Diabetes Res Clin Pract 2015
50
Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6).
John B Buse, Julio Rosenstock, Giorgio Sesti, Wolfgang E Schmidt, Eduard Montanya, Jason H Brett, Marcin Zychma, Lawrence Blonde. Lancet 2009
John B Buse, Julio Rosenstock, Giorgio Sesti, Wolfgang E Schmidt, Eduard Montanya, Jason H Brett, Marcin Zychma, Lawrence Blonde. Lancet 2009
50
DURATION-1: exenatide once weekly produces sustained glycemic control and weight loss over 52 weeks.
John B Buse, Daniel J Drucker, Kristin L Taylor, Terri Kim, Brandon Walsh, Hao Hu, Ken Wilhelm, Michael Trautmann, Larry Z Shen, Lisa E Porter. Diabetes Care 2010
John B Buse, Daniel J Drucker, Kristin L Taylor, Terri Kim, Brandon Walsh, Hao Hu, Ken Wilhelm, Michael Trautmann, Larry Z Shen, Lisa E Porter. Diabetes Care 2010
50
A clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyond.
Lalita Prasad-Reddy, Diana Isaacs. Drugs Context 2015
Lalita Prasad-Reddy, Diana Isaacs. Drugs Context 2015
50
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
Anushka Patel, Stephen MacMahon, John Chalmers, Bruce Neal, Laurent Billot, Mark Woodward, Michel Marre, Mark Cooper, Paul Glasziou, Diederick Grobbee,[...]. N Engl J Med 2008
Anushka Patel, Stephen MacMahon, John Chalmers, Bruce Neal, Laurent Billot, Mark Woodward, Michel Marre, Mark Cooper, Paul Glasziou, Diederick Grobbee,[...]. N Engl J Med 2008
50
Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis.
Heidi Storgaard, Lise L Gluud, Cathy Bennett, Magnus F Grøndahl, Mikkel B Christensen, Filip K Knop, Tina Vilsbøll. PLoS One 2016
Heidi Storgaard, Lise L Gluud, Cathy Bennett, Magnus F Grøndahl, Mikkel B Christensen, Filip K Knop, Tina Vilsbøll. PLoS One 2016
50
The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus.
David Zi Cherney, Bruce A Perkins, Nima Soleymanlou, Ronnie Har, Nora Fagan, Odd Erik Johansen, Hans-Juergen Woerle, Maximilian von Eynatten, Uli C Broedl. Cardiovasc Diabetol 2014
David Zi Cherney, Bruce A Perkins, Nima Soleymanlou, Ronnie Har, Nora Fagan, Odd Erik Johansen, Hans-Juergen Woerle, Maximilian von Eynatten, Uli C Broedl. Cardiovasc Diabetol 2014
50
Meta-analyses of the effects of DPP-4 inhibitors, SGLT2 inhibitors and GLP1 receptor analogues on cardiovascular death, myocardial infarction, stroke and hospitalization for heart failure.
Binayak Sinha, Samit Ghosal. Diabetes Res Clin Pract 2019
Binayak Sinha, Samit Ghosal. Diabetes Res Clin Pract 2019
50
Including known covariates can reduce power to detect genetic effects in case-control studies.
Matti Pirinen, Peter Donnelly, Chris C A Spencer. Nat Genet 2012
Matti Pirinen, Peter Donnelly, Chris C A Spencer. Nat Genet 2012
25
Endogenous Glucose Production and Hormonal Changes in Response to Canagliflozin and Liraglutide Combination Therapy.
Robert Martinez, Hussein Al-Jobori, Ali M Ali, John Adams, Muhammad Abdul-Ghani, Curtis Triplitt, Ralph A DeFronzo, Eugenio Cersosimo. Diabetes 2018
Robert Martinez, Hussein Al-Jobori, Ali M Ali, John Adams, Muhammad Abdul-Ghani, Curtis Triplitt, Ralph A DeFronzo, Eugenio Cersosimo. Diabetes 2018
25
25
The role of glucagon in the possible mechanism of cardiovascular mortality reduction in type 2 diabetes patients.
Marko Skelin, Eugen Javor, Marko Lucijanić, Tomo Lucijanić, Lejsa Jakupović, Dario Rahelić. Int J Clin Pract 2018
Marko Skelin, Eugen Javor, Marko Lucijanić, Tomo Lucijanić, Lejsa Jakupović, Dario Rahelić. Int J Clin Pract 2018
25
Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.
Marie Verbanck, Chia-Yen Chen, Benjamin Neale, Ron Do. Nat Genet 2018
Marie Verbanck, Chia-Yen Chen, Benjamin Neale, Ron Do. Nat Genet 2018
25
Genomic atlas of the human plasma proteome.
Benjamin B Sun, Joseph C Maranville, James E Peters, David Stacey, James R Staley, James Blackshaw, Stephen Burgess, Tao Jiang, Ellie Paige, Praveen Surendran,[...]. Nature 2018
Benjamin B Sun, Joseph C Maranville, James E Peters, David Stacey, James R Staley, James Blackshaw, Stephen Burgess, Tao Jiang, Ellie Paige, Praveen Surendran,[...]. Nature 2018
25
Interpreting findings from Mendelian randomization using the MR-Egger method.
Stephen Burgess, Simon G Thompson. Eur J Epidemiol 2017
Stephen Burgess, Simon G Thompson. Eur J Epidemiol 2017
25
The New Biology and Pharmacology of Glucagon.
T D Müller, B Finan, C Clemmensen, R D DiMarchi, M H Tschöp. Physiol Rev 2017
T D Müller, B Finan, C Clemmensen, R D DiMarchi, M H Tschöp. Physiol Rev 2017
25
A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease.
Majid Nikpay, Anuj Goel, Hong-Hee Won, Leanne M Hall, Christina Willenborg, Stavroula Kanoni, Danish Saleheen, Theodosios Kyriakou, Christopher P Nelson, Jemma C Hopewell,[...]. Nat Genet 2015
Majid Nikpay, Anuj Goel, Hong-Hee Won, Leanne M Hall, Christina Willenborg, Stavroula Kanoni, Danish Saleheen, Theodosios Kyriakou, Christopher P Nelson, Jemma C Hopewell,[...]. Nat Genet 2015
25
Genetic determinants of circulating GIP and GLP-1 concentrations.
Peter Almgren, Andreas Lindqvist, Ulrika Krus, Liisa Hakaste, Emilia Ottosson-Laakso, Olof Asplund, Emily Sonestedt, Rashmi B Prasad, Esa Laurila, Marju Orho-Melander,[...]. JCI Insight 2017
Peter Almgren, Andreas Lindqvist, Ulrika Krus, Liisa Hakaste, Emilia Ottosson-Laakso, Olof Asplund, Emily Sonestedt, Rashmi B Prasad, Esa Laurila, Marju Orho-Melander,[...]. JCI Insight 2017
25
The Role of Glucagon in the Pathophysiology and Treatment of Type 2 Diabetes.
Sofie Hædersdal, Asger Lund, Filip K Knop, Tina Vilsbøll. Mayo Clin Proc 2018
Sofie Hædersdal, Asger Lund, Filip K Knop, Tina Vilsbøll. Mayo Clin Proc 2018
25
Hemodynamic Effects of Glucagon: A Literature Review.
Kasper Meidahl Petersen, Søren Bøgevig, Jens Juul Holst, Filip Krag Knop, Mikkel Bring Christensen. J Clin Endocrinol Metab 2018
Kasper Meidahl Petersen, Søren Bøgevig, Jens Juul Holst, Filip Krag Knop, Mikkel Bring Christensen. J Clin Endocrinol Metab 2018
25
The glucagon receptor is required for the adaptive metabolic response to fasting.
Christine Longuet, Elaine M Sinclair, Adriano Maida, Laurie L Baggio, Marlena Maziarz, Maureen J Charron, Daniel J Drucker. Cell Metab 2008
Christine Longuet, Elaine M Sinclair, Adriano Maida, Laurie L Baggio, Marlena Maziarz, Maureen J Charron, Daniel J Drucker. Cell Metab 2008
25
Exploring the Causal Pathway From Telomere Length to Coronary Heart Disease: A Network Mendelian Randomization Study.
Yiqiang Zhan, Ida K Karlsson, Robert Karlsson, Annika Tillander, Chandra A Reynolds, Nancy L Pedersen, Sara Hägg. Circ Res 2017
Yiqiang Zhan, Ida K Karlsson, Robert Karlsson, Annika Tillander, Chandra A Reynolds, Nancy L Pedersen, Sara Hägg. Circ Res 2017
25
MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data.
Olena O Yavorska, Stephen Burgess. Int J Epidemiol 2017
Olena O Yavorska, Stephen Burgess. Int J Epidemiol 2017
25
Glucose control of glucagon secretion-'There's a brand-new gimmick every year'.
Erik Gylfe. Ups J Med Sci 2016
Erik Gylfe. Ups J Med Sci 2016
25
Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.
Eleanor Wheeler, Aaron Leong, Ching-Ti Liu, Marie-France Hivert, Rona J Strawbridge, Clara Podmore, Man Li, Jie Yao, Xueling Sim, Jaeyoung Hong,[...]. PLoS Med 2017
Eleanor Wheeler, Aaron Leong, Ching-Ti Liu, Marie-France Hivert, Rona J Strawbridge, Clara Podmore, Man Li, Jie Yao, Xueling Sim, Jaeyoung Hong,[...]. PLoS Med 2017
25
Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association.
Salim S Virani, Alvaro Alonso, Emelia J Benjamin, Marcio S Bittencourt, Clifton W Callaway, April P Carson, Alanna M Chamberlain, Alexander R Chang, Susan Cheng, Francesca N Delling,[...]. Circulation 2020
Salim S Virani, Alvaro Alonso, Emelia J Benjamin, Marcio S Bittencourt, Clifton W Callaway, April P Carson, Alanna M Chamberlain, Alexander R Chang, Susan Cheng, Francesca N Delling,[...]. Circulation 2020
25
Glucagon Receptor Antagonism Ameliorates Progression of Heart Failure.
Chen Gao, Shuxun Vincent Ren, Junyi Yu, Ulysis Baal, Dung Thai, John Lu, Chunyu Zeng, Hai Yan, Yibin Wang. JACC Basic Transl Sci 2019
Chen Gao, Shuxun Vincent Ren, Junyi Yu, Ulysis Baal, Dung Thai, John Lu, Chunyu Zeng, Hai Yan, Yibin Wang. JACC Basic Transl Sci 2019
25
Metabolic effects of glucagon in humans.
María M Adeva-Andany, Raquel Funcasta-Calderón, Carlos Fernández-Fernández, Elvira Castro-Quintela, Natalia Carneiro-Freire. J Clin Transl Endocrinol 2018
María M Adeva-Andany, Raquel Funcasta-Calderón, Carlos Fernández-Fernández, Elvira Castro-Quintela, Natalia Carneiro-Freire. J Clin Transl Endocrinol 2018
25
Modulation of Glucagon Signaling: A Metabolic Approach for Heart Failure?
Alessandro Pocai. JACC Basic Transl Sci 2019
Alessandro Pocai. JACC Basic Transl Sci 2019
33
The MR-Base platform supports systematic causal inference across the human phenome.
Gibran Hemani, Jie Zheng, Benjamin Elsworth, Kaitlin H Wade, Valeriia Haberland, Denis Baird, Charles Laurin, Stephen Burgess, Jack Bowden, Ryan Langdon,[...]. Elife 2018
Gibran Hemani, Jie Zheng, Benjamin Elsworth, Kaitlin H Wade, Valeriia Haberland, Denis Baird, Charles Laurin, Stephen Burgess, Jack Bowden, Ryan Langdon,[...]. Elife 2018
25
Mechanisms linking red blood cell disorders and cardiovascular diseases.
Ioana Mozos. Biomed Res Int 2015
Ioana Mozos. Biomed Res Int 2015
25
Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic.
Jack Bowden, Fabiola Del Greco M, Cosetta Minelli, George Davey Smith, Nuala A Sheehan, John R Thompson. Int J Epidemiol 2016
Jack Bowden, Fabiola Del Greco M, Cosetta Minelli, George Davey Smith, Nuala A Sheehan, John R Thompson. Int J Epidemiol 2016
25
Instrumental variable estimation of causal risk ratios and causal odds ratios in Mendelian randomization analyses.
Tom M Palmer, Jonathan A C Sterne, Roger M Harbord, Debbie A Lawlor, Nuala A Sheehan, Sha Meng, Raquel Granell, George Davey Smith, Vanessa Didelez. Am J Epidemiol 2011
Tom M Palmer, Jonathan A C Sterne, Roger M Harbord, Debbie A Lawlor, Nuala A Sheehan, Sha Meng, Raquel Granell, George Davey Smith, Vanessa Didelez. Am J Epidemiol 2011
25
Genetic predictors of testosterone and their associations with cardiovascular disease and risk factors: A Mendelian randomization investigation.
C Mary Schooling, Shan Luo, Shiu Lun Au Yeung, Deborah J Thompson, Savita Karthikeyan, Thomas R Bolton, Amy M Mason, Erik Ingelsson, Stephen Burgess. Int J Cardiol 2018
C Mary Schooling, Shan Luo, Shiu Lun Au Yeung, Deborah J Thompson, Savita Karthikeyan, Thomas R Bolton, Amy M Mason, Erik Ingelsson, Stephen Burgess. Int J Cardiol 2018
25
Recent Progress in the Use of Glucagon and Glucagon Receptor Antago-nists in the Treatment of Diabetes Mellitus.
Mohamed Lotfy, Huba Kalasz, Gyorgy Szalai, Jaipaul Singh, Ernest Adeghate. Open Med Chem J 2014
Mohamed Lotfy, Huba Kalasz, Gyorgy Szalai, Jaipaul Singh, Ernest Adeghate. Open Med Chem J 2014
25
Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps.
Anubha Mahajan, Daniel Taliun, Matthias Thurner, Neil R Robertson, Jason M Torres, N William Rayner, Anthony J Payne, Valgerdur Steinthorsdottir, Robert A Scott, Niels Grarup,[...]. Nat Genet 2018
Anubha Mahajan, Daniel Taliun, Matthias Thurner, Neil R Robertson, Jason M Torres, N William Rayner, Anthony J Payne, Valgerdur Steinthorsdottir, Robert A Scott, Niels Grarup,[...]. Nat Genet 2018
25
Association analyses based on false discovery rate implicate new loci for coronary artery disease.
Christopher P Nelson, Anuj Goel, Adam S Butterworth, Stavroula Kanoni, Tom R Webb, Eirini Marouli, Lingyao Zeng, Ioanna Ntalla, Florence Y Lai, Jemma C Hopewell,[...]. Nat Genet 2017
Christopher P Nelson, Anuj Goel, Adam S Butterworth, Stavroula Kanoni, Tom R Webb, Eirini Marouli, Lingyao Zeng, Ioanna Ntalla, Florence Y Lai, Jemma C Hopewell,[...]. Nat Genet 2017
25
Glucagon increases contractility in ventricle but not in atrium of the rat heart.
Carmen Gonzalez-Muñoz, Susana Nieto-Cerón, Juan Cabezas-Herrera, Jesús Hernández-Cascales. Eur J Pharmacol 2008
Carmen Gonzalez-Muñoz, Susana Nieto-Cerón, Juan Cabezas-Herrera, Jesús Hernández-Cascales. Eur J Pharmacol 2008
25
Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors.
Stephen Burgess, Robert A Scott, Nicholas J Timpson, George Davey Smith, Simon G Thompson. Eur J Epidemiol 2015
Stephen Burgess, Robert A Scott, Nicholas J Timpson, George Davey Smith, Simon G Thompson. Eur J Epidemiol 2015
25
Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies.
Wei Zhou, Jonas B Nielsen, Lars G Fritsche, Rounak Dey, Maiken E Gabrielsen, Brooke N Wolford, Jonathon LeFaive, Peter VandeHaar, Sarah A Gagliano, Aliya Gifford,[...]. Nat Genet 2018
Wei Zhou, Jonas B Nielsen, Lars G Fritsche, Rounak Dey, Maiken E Gabrielsen, Brooke N Wolford, Jonathon LeFaive, Peter VandeHaar, Sarah A Gagliano, Aliya Gifford,[...]. Nat Genet 2018
25
Targeting the glucagon receptor improves cardiac function and enhances insulin sensitivity following a myocardial infarction.
Qutuba G Karwi, Liyan Zhang, Cory S Wagg, Wang Wang, Manoj Ghandi, Dung Thai, Hai Yan, John R Ussher, Gavin Y Oudit, Gary D Lopaschuk. Cardiovasc Diabetol 2019
Qutuba G Karwi, Liyan Zhang, Cory S Wagg, Wang Wang, Manoj Ghandi, Dung Thai, Hai Yan, John R Ussher, Gavin Y Oudit, Gary D Lopaschuk. Cardiovasc Diabetol 2019
25
Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes.
Rury R Holman, Harald Sourij, Robert M Califf. Lancet 2014
Rury R Holman, Harald Sourij, Robert M Califf. Lancet 2014
25
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.